Orthopediatrics (KIDS) Common Equity (2016 - 2026)

Orthopediatrics (KIDS) has 11 years of Common Equity data on file, last reported at $338.7 million in Q1 2026.

• On a quarterly basis, Common Equity fell 2.43% year-over-year to $338.7 million in Q1 2026; TTM through Mar 2026 was $338.7 million, a 2.43% decrease from a year earlier, with the FY2025 full-year figure at $346.6 million, down 2.25% from the prior year.
• Common Equity for Q1 2026 stood at $338.7 million, down from $346.6 million in the prior quarter.
• Over the last five years, Common Equity for KIDS reached as high as $383.3 million in Q3 2022 and fell as low as $215.0 million in Q1 2022.
• Historically, Common Equity has averaged $347.9 million across 5 years, with a median of $370.6 million in 2024.
• Across the five-year window, Common Equity jumped 73.52% in 2023 and slipped 6.32% in 2025, its largest moves.
• Year by year, Common Equity stood at $378.6 million in 2022, then declined by 0.43% to $377.0 million in 2023, then declined by 5.96% to $354.6 million in 2024, then slipped by 2.25% to $346.6 million in 2025, then fell by 2.27% to $338.7 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $338.7 million in Q1 2026, $346.6 million in Q4 2025, and $349.3 million in Q3 2025.